Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 3:38 pm Purchase |
2023-12-31 | 13G | GeoVax Labs, Inc. GOVX |
Armistice Capital, LLC | 3,111,069 9.990% |
3,111,069 (New Position) |
Filing History |
| 2024-02-14 3:37 pm Purchase |
2023-12-31 | 13G | Greenlane Holdings, Inc. GNLN |
Armistice Capital, LLC | 34,640 9.990% |
34,640 (New Position) |
Filing History |
| 2024-02-14 3:37 pm Purchase |
2023-12-31 | 13G | FibroGen, Inc. FGEN |
Armistice Capital, LLC | 9,764,000 9.930% |
9,764,000 (New Position) |
Filing History |
| 2024-02-14 3:36 pm Purchase |
2023-12-31 | 13G | Eyenovia, Inc. EYEN |
Armistice Capital, LLC | 54,725 9.700% |
54,725 (New Position) |
Filing History |
| 2024-02-14 3:36 pm Purchase |
2023-12-31 | 13G | Erasca, Inc. ERAS |
Armistice Capital, LLC | 8,096,000 5.360% |
8,096,000 (New Position) |
Filing History |
| 2024-02-14 3:36 pm Purchase |
2023-12-31 | 13G | Enveric Biosciences, Inc. ENVB |
Armistice Capital, LLC | 1,214 9.990% |
1,214 (New Position) |
Filing History |
| 2024-02-14 3:35 pm Purchase |
2023-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
Armistice Capital, LLC | 2,442,742 9.990% |
2,442,742 (New Position) |
Filing History |
| 2024-02-14 3:35 pm Purchase |
2023-12-31 | 13G | Dermata Therapeutics, Inc. DRMA |
Armistice Capital, LLC | 27,474 9.990% |
27,474 (New Position) |
Filing History |
| 2024-02-14 3:34 pm Purchase |
2023-12-31 | 13G | Draganfly Inc. DPRO |
Armistice Capital, LLC | 197,559 9.990% |
197,559 (New Position) |
Filing History |
| 2024-02-14 3:34 pm Purchase |
2023-12-31 | 13G | Cadrenal Therapeutics, Inc. Common Stock CVKD |
Armistice Capital, LLC | 93,292 9.990% |
93,292 (New Position) |
Filing History |
| 2024-02-14 3:33 pm Purchase |
2023-12-31 | 13G | Cosmos Health Inc. COSM |
Armistice Capital, LLC | 1,504,111 9.990% |
1,504,111 (New Position) |
Filing History |
| 2024-02-14 3:32 pm Purchase |
2023-12-31 | 13G | Coeptis Therapeutics, Inc. COEP |
Armistice Capital, LLC | 176,000 9.960% |
176,000 (New Position) |
Filing History |
| 2024-02-14 3:32 pm Purchase |
2023-12-31 | 13G | Can-Fite BioPharma Ltd. CANF |
Armistice Capital, LLC | 653,946 9.990% |
653,946 (New Position) |
Filing History |
| 2024-02-14 3:31 pm Purchase |
2023-12-31 | 13G | BioSig Technologies, Inc. BSGM |
Armistice Capital, LLC | 5,600,000 6.360% |
5,600,000 (New Position) |
Filing History |
| 2024-02-14 3:31 pm Purchase |
2023-12-31 | 13G | The Beachbody Company, Inc. BODI |
Armistice Capital, LLC | 401,907 9.990% |
401,907 (New Position) |
Filing History |
| 2024-02-14 3:30 pm Purchase |
2023-12-31 | 13G | BIO-key International, Inc. BKYI |
Armistice Capital, LLC | 121,494 9.990% |
121,494 (New Position) |
Filing History |
| 2024-02-14 3:29 pm Purchase |
2023-12-31 | 13G | Bluejay Diagnostics, Inc. BJDX |
Armistice Capital, LLC | 486 9.990% |
486 (New Position) |
Filing History |
| 2024-02-14 3:28 pm Purchase |
2023-12-31 | 13G | Biofrontera Inc. BFRI |
Armistice Capital, LLC | 168,105 9.990% |
168,105 (New Position) |
Filing History |
| 2024-02-14 3:27 pm Purchase |
2023-12-31 | 13G | Aurinia Pharmaceuticals Inc. AUPH |
Armistice Capital, LLC | 9,536,000 6.640% |
9,536,000 (New Position) |
Filing History |
| 2024-02-14 3:27 pm Purchase |
2023-12-31 | 13G | 180 Life Sciences Corp. ATNF |
Armistice Capital, LLC | 58,552 9.990% |
58,552 (New Position) |
Filing History |